A compounding leader takes issue with FDA's position that compounding is the production of a new drug that needs to be approved.
L.D. King
Advertisement
Articles by L.D. King
Advertisement
Latest Updated Articles
- FDA's stand on compounding is bad for R.Ph.s and patients
Published: December 10th 2007 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Evolving Regulatory Criteria Fuel Rx-to-OTC Rejections
2
Chronic Corticosteroid Use Harms Health, Increases Cost for Patients With Asthma
3
Plant-Based Diet Shows Potential in Active Diabetes Remission
4
Pharmacy Law Lowdown: Legislative Shifts in 2026 PBM Reform
5